Search details
1.
An open-label, single-arm, phase 2 trial of panitumumab plus FOLFIRI as second-line therapy in patients with metastatic colorectal cancer.
Clin Colorectal Cancer
; 10(3): 171-7, 2011 Sep.
Article
in English
| MEDLINE | ID: mdl-21855038
Results
1 -
1
de 1
1
Next >
>>